Category: New products
-
FDA Halts Off-the-Shelf T-Cell Cancer Trials
The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Partnership Seeks Lower-Cost Protein Drugs
A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs.
-
Elephant Genetic Codes to be Sequenced, Preserved
A biotechnology company using gene editing to preserve animal species is sequencing the genomes of three elephant varieties to help prevent their extinction.
-
Genomic Analysis Shown to Detect Early Pancreatic Cancer
Analysis of genomic and protein indicators in blood samples is shown to detect pancreatic cancer in earlier stages, increasing chances of survival.
-
Trial Begins Testing RNA Therapy for Alcohol Disorder
A clinical trial is underway testing a therapy that silences genes to create reactions in people with alcohol use disorder to help them stop drinking.
-
Covid-19 Nasal Spray Vaccine Trial Underway
A clinical trial testing the safety of a Covid-19 vaccine from an engineered virus found in dogs and given as a nasal spray enrolled its first participant.
-
Off-the-Shelf Stem Cell Company Forms, Gains $72M
A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds.
-
Gene Therapy Delivery Company Gains $26M in Early Funds
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round.
-
Trial Underway Testing Cancer Drug as Covid-19 Therapy
A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections.